Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
BJS Open2019Vol. 3(6), pp. 812–821
Citations Over TimeTop 14% of 2019 papers
Judith E. K. R. Hentzen, Willemijn Y. van der Plas, Reickly D. N. Constansia, Lukas B. Been, Frederik J.H. Hoogwater, Robert J. van Ginkel, Gooitzen M. van Dam, Patrick Hemmer, Schelto Kruijff
Abstract
Routinely performing DLS in patients with suspicion of colorectal PM to evaluate suitability for CRS + HIPEC is feasible and safe, avoiding the morbidity of an unnecessary laparotomy in patients with extensive disease.
Related Papers
- → Morbidity, mortality and long-term survival in patients undergoing extended cytoreductive surgery with hyperthermic intraperitoneal chemotherapy(2012)
- → Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases in patients with colorectal cancer(2021)
- → 02 / Postoperative outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)(2018)
- → Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)(2023)
- → Health-related quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is not different than cytoreductive surgery alone in primary ovarian cancer patients (009)(2023)